Head-To-Head Survey: Nanovibronix vs. TransEnterix

A comparison of the two small-cap manufacturing companies

Published on Feb. 14, 2026

Got story updates? Submit your updates here. ›

Nanovibronix (NASDAQ:FEED) and TransEnterix (OTCMKTS:TRXDW) are both small-cap manufacturing companies, but which one is the superior stock? This article contrasts the two companies based on factors like profitability, dividends, valuation, institutional ownership, analyst recommendations, earnings, and risk.

Why it matters

Understanding the relative strengths and weaknesses of these two small-cap manufacturing companies can help investors make more informed decisions about which stock to invest in.

The details

The article provides a detailed comparison of Nanovibronix and TransEnterix across several key metrics, including gross revenue, earnings per share, valuation, net margins, return on equity, return on assets, beta, and analyst ratings. It also provides background information on the business operations of each company.

  • The article was published on February 14, 2026.

The players

Nanovibronix

A medical device company focused on creating products using low-intensity, surface acoustic wave technology. Its catheter-based products include the UroShield and NG-Shield devices.

TransEnterix

A medical device company that engages in the research, development, and sale of robotic surgical systems, including the Senhance System and SurgiBot System. It is headquartered in Morrisville, North Carolina.

Got photos? Submit your photos here. ›

The takeaway

This comparison of Nanovibronix and TransEnterix highlights the key differences between the two small-cap manufacturing companies, providing investors with valuable information to consider when deciding which stock to invest in.